Showing results (151-160 of 209) with videos related to
Sort By:
Pageof 21
Sexual Health|November 23, 2006
Bacterial vaginosis in women of low socioeconomic status living in slum areas in Chennai, IndiaShanmugasundaram Uma, Pachamuthu Balakrishnan, Kailapuri G Murugavel, et al.Vaccine|December 15, 2010
Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigenMauricio A Arias, Andrew Loxley, Christy Eatmon, et al.AIDS Research and Human Retroviruses|April 4, 2015
Differences in Evolution of HIV-1 Subtype C Reverse Transcriptase Between Children and Adults Likely Explained by Maturity of Cytotoxic T-Lymphocyte ResponsesShanmugam Saravanan, Selvamurthi Gomathi, Bagavathi Kausalya, et al.Plos Neglected Tropical Diseases|July 17, 2015
The Hidden Burden of Dengue and Chikungunya in Chennai, IndiaIsabel Rodríguez-Barraquer, Sunil S Solomon, Periaswamy Kuganantham, et al.AIDS and Behavior|July 15, 2010
High prevalence of forced sex among non-brothel based, wine shop centered sex workers in Chennai, IndiaVivian F Go, Aylur K Srikrishnan, Corette Breeden Parker, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 16, 2009
High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settingsN Kumarasamy, Vidya Madhavan, Kartik K Venkatesh, et al.BMC Public Health|January 18, 2011
The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, IndiaSunil S Solomon, Aylur K Srikrishnan, David D Celentano, et al.AIDS and Behavior|April 11, 2006
Perceptions about the acceptability of assessments of HIV medication adherence in Lilongwe, Malawi and Chennai, IndiaSteven A Safren, N Kumarasamy, Mina Hosseinipour, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 12, 2016
Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure ProphylaxisJulie Fox, Juan M Tiraboschi, Carolina Herrera, et al.Vaccine|July 13, 2025
Development of a live-attenuated vaccine challenge model of Yersinia pestis in humans: Expert consultation on clinical trial considerations, January 2025Anna Rydlova, Emma Smith, Arabella Stuart, et al.Pageof 21